|
Volumn 12, Issue 18, 2006, Pages 2187-
|
Editorial: Ion channels as a target for drug design
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIARRHYTHMIC AGENT;
CALCIUM ACTIVATED POTASSIUM CHANNEL;
CALCIUM CHANNEL T TYPE;
ENZYME INHIBITOR;
ION CHANNEL;
MUTANT PROTEIN;
POTASSIUM CHANNEL BLOCKING AGENT;
POTASSIUM CHANNEL HERG;
SODIUM CHANNEL;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
VOLTAGE GATED CHANNEL FORMING PROTEIN;
VOLTAGE GATED POTASSIUM CHANNEL;
ALPHA CHAIN;
APOPTOSIS;
CHANNEL GATING;
CYSTIC FIBROSIS;
DIARRHEA;
DRUG DESIGN;
DRUG POTENCY;
DRUG TARGETING;
EDITORIAL;
ENZYME INHIBITION;
EPILEPSY;
HEART REPOLARIZATION;
HEART RHYTHM;
HUMAN;
HYPERTENSION;
IN VIVO STUDY;
INDUSTRIALIZATION;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY EPITHELIUM;
MITOCHONDRION;
MORTALITY;
MULTIPLE SCLEROSIS;
NOCICEPTION;
PAIN;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN FUNCTION;
REPOLARIZATION;
SYNAPTIC TRANSMISSION;
T LYMPHOCYTE ACTIVATION;
|
EID: 33745146858
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/138161206777585166 Document Type: Editorial |
Times cited : (1)
|
References (7)
|